BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20142768)

  • 1. Adenoviral gene delivery of pigment epithelium-derived factor protects striatal neurons from quinolinic acid-induced excitotoxicity.
    Sanagi T; Yabe T; Yamada H
    J Neuropathol Exp Neurol; 2010 Mar; 69(3):224-33. PubMed ID: 20142768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of PEDF attenuates ischemic brain damage in the rat middle cerebral artery occlusion model.
    Sanagi T; Yabe T; Yamada H
    J Neurochem; 2008 Aug; 106(4):1841-54. PubMed ID: 18624913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in pigment epithelium-derived factor expression following kainic acid induced cerebellar lesion in rat.
    Sanagi T; Yabe T; Yamada H
    Neurosci Lett; 2007 Aug; 424(1):66-71. PubMed ID: 17709187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
    Wang JJ; Zhang SX; Mott R; Chen Y; Knapp RR; Cao W; Ma JX
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1166-73. PubMed ID: 18322021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential.
    Barnstable CJ; Tombran-Tink J
    Prog Retin Eye Res; 2004 Sep; 23(5):561-77. PubMed ID: 15302351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cerebellar granule cell neurons with the neurotrophic factor pigment epithelium-derived factor in vitro enhances expression of other neurotrophic factors as well as cytokines and chemokines.
    Yabe T; Herbert JT; Takanohashi A; Schwartz JP
    J Neurosci Res; 2004 Sep; 77(5):642-52. PubMed ID: 15352210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the neuroprotective activity of pigment epithelium-derived factor in a rat model of retinal degeneration.
    Murakami Y; Ikeda Y; Yonemitsu Y; Onimaru M; Nakagawa K; Kohno R; Miyazaki M; Hisatomi T; Nakamura M; Yabe T; Hasegawa M; Ishibashi T; Sueishi K
    Am J Pathol; 2008 Nov; 173(5):1326-38. PubMed ID: 18845835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
    Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
    Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
    Yasuda T; Fukuda-Tani M; Nihira T; Wada K; Hattori N; Mizuno Y; Mochizuki H
    Exp Neurol; 2007 Aug; 206(2):308-17. PubMed ID: 17604022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model.
    Browne M; Stellmach V; Cornwell M; Chung C; Doll JA; Lee EJ; Jameson JL; Reynolds M; Superina RA; Abramson LP; Crawford SE
    Pediatr Res; 2006 Sep; 60(3):282-7. PubMed ID: 16857775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization.
    Zhou XY; Liao Q; Pu YM; Tang YQ; Gong X; Li J; Xu Y; Wang ZG
    Chin Med J (Engl); 2009 Nov; 122(22):2711-7. PubMed ID: 19951601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
    Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
    Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic receptor regulation of pigment epithelial-derived factor expression in rat retina.
    Lashbrook BL; Steinle JJ
    Auton Neurosci; 2005 Aug; 121(1-2):33-9. PubMed ID: 15961351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor.
    Takita H; Yoneya S; Gehlbach PL; Duh EJ; Wei LL; Mori K
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4497-504. PubMed ID: 14507898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
    Mori K; Duh E; Gehlbach P; Ando A; Takahashi K; Pearlman J; Mori K; Yang HS; Zack DJ; Ettyreddy D; Brough DE; Wei LL; Campochiaro PA
    J Cell Physiol; 2001 Aug; 188(2):253-63. PubMed ID: 11424092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian lentiviral vector-mediated retinal gene transfer of pigment epithelium-derived factor protects retinal degeneration and electrical defect in Royal College of Surgeons rats.
    Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Sakamoto T; Tabata T; Ueda Y; Hasegawa M; Tobimatsu S; Ishibashi T; Sueishi K
    Gene Ther; 2003 Aug; 10(17):1503-11. PubMed ID: 12900766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleeping Beauty transposon-mediated transfection of retinal and iris pigment epithelial cells.
    Johnen S; Izsvák Z; Stöcker M; Harmening N; Salz AK; Walter P; Thumann G
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4787-96. PubMed ID: 22729435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pigment epithelium-derived factor gene therapy inhibits the growth of transplanted human hepatocellular carcinoma in nude mice].
    GAO Y; ZHANG W; ZHAO L; WANG XH
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):363-7. PubMed ID: 19497203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.